Aerosol-based treatment could dramatically reduce the number of new coronavirus patients dying from the disease or requiring intensive care, according to preliminary results published Monday by a British biotech firm. In a randomized trial of 100 hospitalized patients with COVID-19, those who received an inhaled formula of the protein interferon …
Read More »
A British pharmaceutical company said Monday that positive results from a clinical trial of a new coronavirus respiratory treatment could indicate a “breakthrough” in the global fight to stop the spread of COVID-19. Synairgen, a respiratory drug discovery and development company, said in a press release that an initial trial …
Read More »
People who have been seriously ill and treated in intensive care units can wait a few months to fully recover, regardless of their condition. However, with COVID-19, the evidence is mounting that some people who have had relatively mild symptoms at home may also have prolonged illness. Overwhelming fatigue, palpitations, …
Read More »
Drug makers associated with the United States government are on track to begin actively manufacturing a COVID-19 vaccine by the end of the summer, a senior administration official said Monday. “If you say exactly when the vaccine materials will literally be in production and manufacturing, it will likely be four …
Read More »
On June 29, the Food and Drug Administration (FDA) approved Phesgo, a breast cancer treatment that health professionals can administer at home. Phesgo is a fixed-dose combination of two monoclonal antibodies and enables the treatment of early and metastatic HER2 positive breast cancer for outpatients. The two monoclonal antibodies are …
Read More »